Healios K.K. (HLOSF)
USD 1.35
(0.0%)
USD 1.35
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.15 Billion JPY | 13122.92% |
| 2022 | 114.61 Million JPY | -44.95% |
| 2021 | 208.21 Million JPY | -7.23% |
| 2020 | 224.42 Million JPY | -4.71% |
| 2019 | 235.5 Million JPY | -98.43% |
| 2018 | 14.98 Billion JPY | -23.95% |
| 2017 | 19.69 Billion JPY | 114.68% |
| 2016 | 9.17 Billion JPY | 10423.88% |
| 2015 | 87.18 Million JPY | -97.25% |
| 2014 | 3.17 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 17.81 Billion JPY | 8.05% |
| 2024 Q1 | 108.9 Million JPY | 8.77% |
| 2023 Q1 | 114.33 Million USD | -0.24% |
| 2023 FY | 15.15 Billion JPY | 13122.92% |
| 2023 Q3 | 120.25 Million USD | 18.15% |
| 2023 Q4 | 107.4 Million USD | -10.69% |
| 2023 Q2 | 101.77 Million USD | -10.98% |
| 2022 Q3 | 103.04 Million JPY | -32.6% |
| 2022 FY | 114.61 Million JPY | -44.95% |
| 2022 Q4 | 114.61 Million JPY | 11.22% |
| 2022 Q1 | 22.49 Billion JPY | -6.15% |
| 2022 Q2 | 152.89 Million JPY | -99.32% |
| 2021 Q1 | 200.65 Million JPY | -99.13% |
| 2021 FY | 208.21 Million JPY | -7.23% |
| 2021 Q4 | 23.97 Billion JPY | -8.02% |
| 2021 Q3 | 26.06 Billion JPY | 14217.23% |
| 2021 Q2 | 182.02 Million JPY | -9.28% |
| 2020 FY | 224.42 Million JPY | -4.71% |
| 2020 Q1 | 28.53 Billion JPY | 11.5% |
| 2020 Q2 | 26.39 Billion JPY | -7.51% |
| 2020 Q3 | 24.07 Billion JPY | -8.79% |
| 2020 Q4 | 23.17 Billion JPY | -3.75% |
| 2019 Q1 | 13.56 Billion JPY | -30.87% |
| 2019 Q4 | 25.59 Billion JPY | 14.05% |
| 2019 Q3 | 22.44 Billion JPY | 80.25% |
| 2019 Q2 | 12.45 Billion JPY | -8.19% |
| 2019 FY | 235.5 Million JPY | -98.43% |
| 2018 FY | 14.98 Billion JPY | -23.95% |
| 2018 Q4 | 19.61 Billion JPY | 11.87% |
| 2018 Q2 | 18.45 Billion JPY | -1.99% |
| 2018 Q3 | 17.53 Billion JPY | -4.97% |
| 2018 Q1 | 18.82 Billion JPY | -4.43% |
| 2017 Q3 | 17.02 Billion JPY | 1.73% |
| 2017 FY | 19.69 Billion JPY | 114.68% |
| 2017 Q1 | 10.56 Billion JPY | 15.14% |
| 2017 Q2 | 16.73 Billion JPY | 58.4% |
| 2017 Q4 | 19.69 Billion JPY | 15.7% |
| 2016 FY | 9.17 Billion JPY | 10423.88% |
| 2016 Q4 | 9.17 Billion JPY | -6.41% |
| 2016 Q3 | 9.8 Billion JPY | -5.69% |
| 2016 Q2 | 10.39 Billion JPY | -2.46% |
| 2016 Q1 | 10.65 Billion JPY | 1.62% |
| 2015 FY | 87.18 Million JPY | -97.25% |
| 2015 Q3 | 10.79 Billion JPY | 7.11% |
| 2015 Q2 | 10.08 Billion JPY | 0.0% |
| 2015 Q4 | 10.48 Billion JPY | -2.89% |
| 2014 FY | 3.17 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -38912.022% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -209809.967% |
| SQZ Biotechnologies Company | 107.18 Million USD | -14038.841% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -143494.846% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -11538.824% |
| Mesoblast Limited | 667.9 Million USD | -2169.05% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -20942344.552% |
| Genus plc | 1.02 Billion USD | -1372.932% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -1115589.368% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -3036736.8% |
| Marizyme, Inc. | 22.01 Million USD | -68739.193% |
| ContraFect Corporation | 20.67 Million USD | -73186.909% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -2416965.391% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -3882154.09% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -3965340.097% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -1058186.407% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -365431.104% |
| MultiCell Technologies, Inc. | 126.22 USD | -12006813400.238% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -1612667.628% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -11692.857% |
| EV Biologics, Inc. | 431.71 Thousand USD | -3510325.884% |
| Q BioMed Inc. | 3.51 Million USD | -430988.799% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -42979.678% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -1966437.078% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -5800257.475% |
| Biomind Labs Inc. | 73.81 Thousand USD | -20529844.865% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | -3174.251% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -50391.502% |
| Skye Bioscience, Inc. | 11.94 Million USD | -126821.929% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -457338.729% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -551726.343% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -773829.381% |
| IMV Inc. | 31.33 Million USD | -48266.321% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -2204308.526% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -582068.995% |
| GB Sciences, Inc. | 103.44 Thousand USD | -14650622.144% |
| Alpha Cognition Inc. | 2.45 Million USD | -617924.036% |
| HST Global, Inc. | 1526.00 USD | -993119166.055% |
| CSL Limited | 38.02 Billion USD | 60.141% |
| Halberd Corporation | 10.13 Thousand USD | -149590266.203% |
| Enzolytics Inc. | 361.7 Million USD | -4089.86% |
| Resverlogix Corp. | 8.11 Million USD | -186652.927% |
| Affymax, Inc. | 7.44 Million USD | -203514.134% |
| SYBLEU INC | 330.46 Thousand USD | -4585820.573% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -806927.073% |
| argenx SE | 4.54 Billion USD | -233.63% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -54133.467% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -31670.156% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -66524635.525% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -169245.597% |
| AVAX Technologies, Inc. | 7.37 Million USD | -205331.442% |
| Zenith Capital Corp. | 7410.00 USD | -204520817.679% |
| Genscript Biotech Corporation | 3.38 Billion USD | -347.528% |
| Ember Therapeutics, Inc. | 184.00 USD | -8236412943.478% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -4709259.055% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -5798326.715% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -3295.63% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -1045907.055% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | -500877.493% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -28656.57% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -1633050.531% |
| BioStem Technologies, Inc. | 14.56 Million USD | -103984.458% |
| ONE Bio Corp. | 70.08 Million USD | -21523.587% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -26543845.073% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -656060506.061% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -1533858.118% |
| Agentix Corp. | 261.39 Thousand USD | -5797705.595% |
| LadRx Corporation | 2.3 Million USD | -656562.689% |
| Cell Source, Inc. | 195.17 Thousand USD | -7764885.577% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -3153532.139% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -4285610.246% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -4285610.246% |
| NovAccess Global Inc. | 62.24 Thousand USD | -24346063.732% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -2369142.218% |
| Itoco Inc. | 1.4 Million USD | -1082344.331% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -15842964.282% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -14297069.811% |
| Kadimastem Ltd | 2.3 Million USD | -657646.259% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -19848238.005% |
| CytoDyn Inc. | 11.13 Million USD | -135990.158% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -10599877.618% |
| Mobile Lads Corp. | 52.00 USD | -29144230669.231% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -84759407.83% |
| Qrons Inc. | 420.00 USD | -3608333233.333% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -3931453.865% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -2744774.303% |
| Rebus Holdings, Inc. | 5000.00 USD | -303099900.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -3701459.76% |
| International Stem Cell Corporation | 5.39 Million USD | -281068.831% |
| Bioxytran, Inc. | 137.63 Thousand USD | -11010667.375% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -100921.009% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -91310.821% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -19183444.304% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -1752577.589% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -201509.685% |
| Neutra Corp. | 2851.00 USD | -531567770.922% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -46666.031% |
| PureTech Health plc | 693.97 Million USD | -2083.803% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -187668.962% |
| IXICO plc | 15.84 Million USD | -95551.936% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -182887.201% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -14567.454% |
| CSL Limited | 38.02 Billion USD | 60.141% |
| Cellectis S.A. | 333.99 Million USD | -4437.498% |